2024 HCPCS Code J0751
Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
TAGS: emtricitabine 200mg alafenamide prophylaxis treatment approved tenofovir
Short Description | Hiv prep, ftc/taf 200/25mg |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | January 02, 2024 |
HCPCS Code Added Date | January 02, 2024 |
HCPCS Pricing Indicator Code | 57 - Other carrier priced |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J0219 - Inj aval alfa-nqpt 4mg
- J0220 - Alglucosidase alfa injection
- J0221 - Lumizyme injection
- J0222 - Inj., patisiran, 0.1 mg
- J0223 - Inj givosiran 0.5 mg
- J0224 - Inj. lumasiran, 0.5 mg
- J0225 - Inj, vutrisiran, 1 mg
- J0248 - Inj, remdesivir, 1 mg
- J0256 - Alpha 1 proteinase inhibitor
- J0257 - Glassia injection
- J0270 - Alprostadil for injection
- J0275 - Alprostadil urethral suppos
- J0278 - Amikacin sulfate injection
- J0280 - Aminophyllin 250 mg inj
- J0282 - Amiodarone hcl
- J0283 - Inj, amiodarone (nexterone)
- J0285 - Amphotericin b
- J0287 - Amphotericin b lipid complex
- J0288 - Ampho b cholesteryl sulfate
- J0289 - Amphotericin b liposome inj